Marshall Wace North America’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$294K Sell
6,012
-83,276
-93% -$4.19M ﹤0.01% 1249
2021
Q2
$4.49M Buy
89,288
+72,239
+424% +$3.55M 0.02% 579
2021
Q1
$668K Buy
+17,049
New +$663K ﹤0.01% 1135
2020
Q1
Sell
-729
Closed -$10K 1248
2019
Q4
$10K Sell
729
-2,026
-74% -$41.6K ﹤0.01% 1227
2019
Q3
$89K Buy
+2,755
New +$69.5K ﹤0.01% 1079
2018
Q2
Sell
-103,475
Closed -$3.37M 1404
2018
Q1
$3.37M Buy
+103,475
New +$1.92M 0.02% 662

Other funds holding BXC

Marshall Wace North America's BXC Position: Q3 2021 in Review

Marshall Wace North America reduced its BlueLinx (BXC) stake by 93% in Q3 2021, selling an estimated $4.19M and leaving 6,012 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

Marshall Wace North America first reported a position in BXC in Q1 2018 and has held it in 6 quarters since. The position peaked at $4.49M in Q2 2021. 125 funds tracked by Wall St. Rank hold BXC as of Q3 2021.

  • Marshall Wace North America held 6,012 shares of BlueLinx worth $294K as of Q3 2021.
  • Marshall Wace North America sold 83,276 BlueLinx shares in Q3 2021, an estimated $4.19M.
  • BlueLinx made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1249 holding.
  • Marshall Wace North America first reported a position in BlueLinx in Q1 2018 and has held it in 6 quarters since.
  • Marshall Wace North America's BlueLinx position peaked at $4.49M in Q2 2021.
  • 125 funds tracked by Wall St. Rank held BlueLinx as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.